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Received 11 March 2014; revised 4 November 2014; accepted 17 November 2014; available online 31 December 2014Introduction: The incidence of perforated peptic ulcer remains high in low and middle-income countries. Mortality can be signiﬁcant, and early surgical management
with careful evaluation of pre-operative risk factors is essential. The purpose of this study was to describe the clinical outcomes of surgical treatment for perforated
peptic ulcer disease in Liberia and to explore risk factors for adverse outcomes.
Methods: This study prospectively examined 20 consecutive patients undergoing primary closure with omental patch for perforated pre-pyloric or duodenal peptic
ulcer at the John F. Kennedy Medical Centre (JFKMC) in Monrovia, Liberia from May 2009 to March 2010. Pre-operative information was captured in a question-
naire. Risk factors were assessed for univariate and multivariate associations with in-hospital mortality.
Results: Median age was 33 years and 85% were males. A majority of the patients (70%) had a history of gastritis and antacid use. Median time from beginning of
symptoms to surgery was 4.5 days. Over-all in-hospital mortality following surgical therapy for perforated peptic ulcer disease was 35%. Median length of stay among
survivors was 16 days, and death occurred at median 1 day after admission. Long symptom duration and age >30 years of age were signiﬁcantly associated with in-
hospital mortality on univariate (b= 2.60 [0.18–5.03], p= 0.035) and multivariate testing (b= 2.95 [0.02–5.88], p= 0.049).
Conclusion: Peptic ulcer disease and its treatment represent a potentially substantial source of morbidity and mortality in limited-resource settings. In this case series,
surgical treatment for perforated peptic ulcer disease carried a high mortality, and the results highlight the potential for public health systems strengthening to prevent
poor health outcomes. Peptic ulcer disease in low- and middle-income countries presents unique epidemiology and treatment challenges that may differ signiﬁcantly
from evidence-based guidelines in high-income countries.
Introduction: L’incidence de l’ulce`re gastroduode´nal perfore´ reste e´leve´e dans les pays a` faible et moyen revenu. La mortalite´ peut eˆtre e´leve´e, et la prise en charge
chirurgicale pre´coce, associe´e a` une e´valuation soigne´e des facteurs de risque pre´ope´ratoires, est essentielle. L’objectif de cette e´tude e´tait de de´crire les re´sultats cliniques
du traitement chirurgical des ulce`res gastroduode´naux perfore´s au Liberia et d’e´tudier les facteurs de risque associe´s aux issues de´favorables.
Me´thodes: Cette e´tude s’est penche´e prospectivement sur 20 patients conse´cutifs subissant une fermeture primaire avec patch e´piploı¨que pour traiter l’ulce`re pre´pyl-
orique ou gastroduode´nal perfore´ au Centre me´dical John F. Kennedy (JFKMC) a` Monrovia, au Liberia, de mai 2009 a` mars 2010. Les informations pre´ope´ratoires
ont e´te´ saisies dans un questionnaire. Les facteurs de risque ont e´te´ e´value´s a` des ﬁns d’associations univarie´es et multivarie´es avec la mortalite´ hospitalie`re.
Re´sultats: L’aˆge me´dian e´tait 33 ans et 85% de l’e´chantillon e´tait compose´ d’hommes. Une majorite´ de patients (70%) avait des ante´ce´dents de gastrite et avait eu
recours aux antiacides. Le temps moyen entre l’apparition des symptoˆmes et l’ope´ration e´tait de 4,5 jours. Le taux global de mortalite´ hospitalie`re suite a` une ope´ration
pour ulce`re gastroduode´nal perfore´ s’e´levait a` 35%. La dure´e moyenne de se´jour des survivants e´tait de 16 jours, et les de´ce`s survenaient en moyenne un jour apre`s
d’admission. Des symptoˆmes sur une longue dure´e et un aˆge supe´rieur a` 30 ans e´taient signiﬁcativement associe´s a` la mortalite´ hospitalie`re dans les tests univarie´s
(b= 2,60 [0,18–5,03], p= 0,035) et multivarie´s (b= 2,95 [0,02–5,88], p= 0,049).* Correspondence to J. Fallah Moses. fallahmoses@yahoo.com
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Conclusion: L’ulce`re gastroduode´nal et son traitement repre´sentent une source de morbidite´ et de mortalite´ substantielle potentielle dans des environnements cara-
cte´rise´s par des ressources limite´es. Dans cette se´rie de cas, le traitement chirurgical de l’ulce`re gastroduode´nal perfore´ e´tait associe´ a` une forte mortalite´, et les re´sultats
mettent en avant le potentiel de renforcement des syste`mes de sante´ publique aﬁn d’e´viter des issues de´favorables en termes de sante´. Les ulce`res gastroduode´naux dans
les pays a` faible et moyen revenu pre´sentent des de´ﬁs uniques sur le plan e´pide´miologique et the´rapeutique susceptibles de diffe´rer dans une large mesure des directives
scientiﬁquement fonde´es disponibles dans les pays a` revenu e´leve´.
African relevance
 Approximately 2 billion people world-wide do not have
access to safe surgical services.
 Most African national health systems do not sufﬁciently
provide emergency surgical services.
 Mortality from emergency surgery is high in part due to late
presentation.
 Peptic ulcer presents country-speciﬁc epidemiology and
treatment challenges.
Introduction
The worldwide incidence of peptic ulcer disease has decreased
in recent years,1 largely due to the advent of improved endo-
scopic diagnostics, introduction of proton pump inhibitors
(PPIs), and attention to Helicobacter pylori eradication.2 Still,
peptic ulcer disease remains a signiﬁcant health and economic
burden in low- and middle-income countries (LMICs).3,4
LMICs are often characterized by high prevalence of untreated
H. pylori infection and concomitant environmental exposures
such as NSAIDs or aspirin.5 Additionally, inadequate access
to surgical and anesthesia care can prove devastating in com-
plex and perforated peptic ulcer disease, which affects 7–10/
100.000.5 Overall mortality from perforated peptic ulcer has
been reported at 9% and as high as 22% in LMICs,4,6 even
though early surgical management can be life-saving. Careful
evaluation of pre-operative risk factors is imperative to guide
appropriate clinical management. Thus, data from individual
LMICs about epidemiology of disease and outcomes are criti-
cal to inform such practices.
At the tertiary referral hospital in Monrovia, Liberia, where
this study took place, we observed that a considerable propor-
tion of patients with acute abdomen were diagnosed with gas-
tric perforation. The nature and behavior of clinical disease
seem to be unique, and to our knowledge no study has been
performed on gastric perforation in Liberia. This study aimed
to prospectively determine the clinical outcomes after surgical
treatment for peptic ulcer disease and to explore in-hospital
mortality risk factors. We hypothesized that delayed presenta-
tion to the hospital would have a negative impact on survival.
Methods
In this prospective case-series analysis, we evaluated all 20
patients presenting to the surgical department of J.F.K Medi-
cal Centre, Monrovia, Liberia with acute abdomen from
March 2009 to March 2010, who underwent exploratory lapa-
rotomies and were found to have perforated pre-pyloric or
duodenal peptic ulcer. Patients were identiﬁed, consented,
and interviewed prior to surgical intervention. Factors consid-
ered in the pre-operative questionnaire included: employment
status, income and family responsibility, history of smoking,
history of alcohol use, history of gastritis, antacid use, diet his-
tory, date of onset of the illness and date reporting to the hos-
pital (data supplement: structured questionnaire). The
interviewer was the ﬁrst author, a general practitioner with
over eighteen years of experience in general surgery.
Peptic ulcer perforations were suspected based on medical
history and clinical signs, and the patients often presented after
having been treated in smaller community hospitals or health
centres until they signiﬁcantly deteriorated. Many of the
patients presented with a history of dyspepsia and antacid
use, and they could typically tell almost the exact time of onset
of the pain with subsequent and gradually increasing symp-
toms of peritonitis. Medical history and physical examination
were not able to distinguish perforated peptic ulcer from differ-
ential diagnoses such as typhoid perforation, ruptured appen-
dix and other causes of bowel perforations and peritonitis, and
these patients were excluded from further analysis at the point
of surgery. After a mid-line laparotomy, the patients with pep-
tic ulcer perforation underwent gastrorrhaphy with omental
patch, without placement of intra-abdominal drain. Antibiot-
ics were prescribed on average 3–5 days after the operation.
HIV-status was negative for all included patients. Anesthesia
was usually provided by nurse-anesthetists.
We used Chi-square test to analyze binary data, and
Mann–Whitney U for ordinal data. Select risk factors were
also dichotomized and assessed for associations with in-hospi-
tal mortality by multivariate logistic regression. Long symp-
tom duration was deﬁned as more than 4 days between onset
of illness and surgery. The data were analyzed using the
IBM SPSS v.19.1 (Chicago, IL). The study was approved by
the JFK hospital direction, and by the Institutional Review
Board of Boston Children’s Hospital for the Harvard Program
in Global Surgery and Social Change.
Results
20 patients were treated over the course of the study period.
Demographics and clinical details of patients operated for per-
forated peptic ulcer are presented in Table 1. The median age
of patients was 33 years [interquartile range 26–46]. Most
patients were male (85%) and reported a history of gastritis
and antacid use (70%). All patients underwent operations
within 24 h after presentation to the hospital, and the median
time from initial symptoms to surgery was 4.5 days [interquar-
tile range 4–6]. Overall mortality was 7/20 (35%), and median
time to death was 1 day after presentation [interquartile range
0–4]. Median length of stay among survivors was 16 days
[interquartile range 11–29]. Three sample clinical vignettes
are given in Fig. 1.
Long symptom duration and age >30 years of age were
signiﬁcantly associated with higher in-hospital mortality
(p= 0.02). However, non-survivors did not differ compared
to survivors in terms of median age (39 years. vs. 28 years.,
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p= 0.07), gender (71% male vs. 92% male, p= 0.27), median
duration of symptoms (4 days [3–6] vs. 5 days [5–6], p= 0.08),
previous history of dyspepsia, marital status, employment
status, blood group, or alcohol, and tobacco consumption
(Table 2).
Long symptom duration and age >30 years of age were
also signiﬁcantly associated with in-hospital mortality on
univariate (b= 2.60 [0.18–5.03], p= 0.035) and multivariate
testing (b= 2.95 [0.02–5.88], p= 0.049), compared to short
symptom duration and younger age (Table 3).
Discussion
This study indicates that long symptom duration and older age
are signiﬁcant risk factors associated with in-hospital mortality
after surgical treatment for perforated peptic ulcer disease. The
results highlight the considerable risks involved with surgical
care in low- and middle-income countries, and the fact that
any national health system for surgery must include not only
safe anesthesia and operative capacity, but also prevention
and timely referrals. The high proportion of patients of the
male sex (85%) and with a history of gastritis (70%) implies
that focused education and preventive efforts in this popula-
tion could likely mitigate the incidence of perforated peptic
ulcer.
In LMICs there are numerous hurdles for patients with sur-
gical needs, ranging from cultural perceptions of healthcare,
travel distance and direct and hidden patient costs, to shortage
of operating rooms, safe anesthesia, sterilization capacity, sur-
gical instruments, and surgeons.7 Some of the treatment delays
seen in this study may have been caused by beliefs in tradi-
tional treatments,8 the lack of trained manpower in smaller
clinics to properly diagnose and refer this condition,9 and inad-
equate ﬁnances to pay hospital bills.10 Delays in care likely
increase also the incidence and severity of postoperative com-
plications, such as high rate of sepsis and metabolic
derangement.
One reason for the decrease in peptic ulcer disease in high-
income countries is the increased understanding of ulcer dis-
ease, the dissemination of this information to the public, and
a widespread adoption of proton pump inhibitor use among
primary caregivers. Access to primary treatment and the
Table 1 Demographics and clinical parameters of patients
with perforated peptic ulcer.
n











History of gastritis 14 70%
Previous antacids 14 70%
Smoking 11 55%
Alcohol 16 80%









Symptom debut (days preop) 4.5 [4–6]a
Length of stay (days) 16 [11–29]a
Mortality (days postop) 1 [0–4]a
a Median with [interquartile range].
b n= 17.
Clinical presentations 
1. K: 52 years old male admitted at 5:45 am. Physical findings: axillary temperature 99.7⁰ F, 
respiratory rate 38/minute, Pulse rate 116 beats/minute, BP 118/60 mmHg. He was tachypneic, 
tachycardic, febrile, and with moderate abdominal distention with tenderness. He was dehydrated, 
septic and lethargic, bowel sounds were absent, rectum was empty, hemoglobin 8 gm/dL. 
Electrolyte analysis could not be done. He was resuscitated with Lactated Ringers solution to 
correct assumed fluid and electrolytes imbalances, a unit of blood was transfused, and 
metronidazole and ceftriaxone were infused at admission and immediately prior to surgery. He 
underwent surgery from 5:05 pm to 8:25 pm, twelve hours after hospital presentation.
2. Q: 35 years old female admitted at 9:44 am. Physical findings at presentation: axillary temperature 
102⁰ F, respiratory rate 28 cycles /minute, pulse 114 beats/minute, BP 130/90mmHg. She was 
tachypneic, tachycardic, febrile, septic, mild abdominal distention with tenderness, dehydrated and 
lethargic; and bowel sounds were absent. She underwent surgery at 8: 25 pm, almost eleven hours 
after hospital presentation. 
3. F: 48 years old male admitted at 6am. He came in with abdominal pains and distention, tenderness, 
fever, fast respirations, septic and fast heartbeat. He underwent surgery at 4pm, ten hours after 
admission. He died in the immediate post-operative period despite prolonged aggressive 
resuscitation with blood, IV fluids, antibiotics and oxygen. 
Figure 1 Sample vignettes: Initials, age, and timing of patients have been modiﬁed to protect patient integrity.
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incidence of peptic ulcers and peptic ulcer perforations are also
likely inﬂuenced by socioeconomic factors, particularly in lim-
ited-resource settings.
Our ﬁndings are congruent with what has been demon-
strated in other low-income setting studies examining peptic
ulcer disease. Lohsiriwat and colleagues presented a series of
152 patients (78% male, average age 52 years)6 wherein com-
plication rate was 30% and overall mortality rate was 9%.
The authors noted that the presence of modiﬁable risk factors
and late stage of presentation contributed to higher mortality
in this population. Ohene-Yeboah and colleagues prospec-
tively examined patients from January 1998 to June 2004. Sim-
ilarly in this study, more males were affected by a ratio of
about 3 to 1, with median age of 55 years. There were 244 gas-
tric and 87 duodenal perforations giving a ratio of 2.8 to 1.
Most of these perforations were associated with the intake of
NSAIDS (47.7%). The overall mortality was 22.1%. Age
and mortality were higher for duodenal ulcers. Dakubo and
colleagues examined a total of 326 cases treated for peptic
ulcer perforation, including 267 males and 59 females, with
mean age of about 41 years (range 4–87 years). There was a
strong association with consumption of ulcerogenic substances
(67%). More than half of all patients (54%) reported to the
hospital after 24 h. Post-operative complications occurred in
19%, and overall mortality was 11%. Age >60 years, alcohol
intake and resectional surgery were factors signiﬁcantly associ-
ated with post-operative mortality.
Two known risk factors for peptic ulcer disease were left
unaccounted for in our study: H. pylori infection and ulcero-
genic substance intake. H. pylori infection has been identiﬁed
in 65–70% of patients with perforated peptic ulcer,11 which
is signiﬁcantly lower than the 90–100% prevalence among
patients with non-complicated disease,11 and notably higher
than the 23% prevalence among NSAID users with perfora-
tion.12 During the time of our study, culture results and in-
depth diagnostics of patient comorbidities were commonly
unavailable. Therefore as a representative limitation of many
facilities in LMICs, we were therefore not able to detect H.
pylori, and also many of our patients could not afford the cost
of H. pylori eradication therapy or proton-pump inhibitors.
Furthermore, it should be noted that discharge sometimes is
postponed until the patient or their family can pay the hospital
bill. However, ﬁnancial reasons did not inﬂuence the measure-
ment of length of stay reported in this study, the length of stay
reﬂected the period during which the patient was still undergo-
ing treatment, which means that this outcome was not con-
founded by issues related to poverty and socioeconomic




Median agea 13 28 [25–40] 7 39 [36–49] 0.07
Age <30 years 9/13 69% 1/7 14%
Age >30 years 4/13 31% 6/7 86% 0.02
Female gender 1/13 8% 2/7 29% 0.27
Days of symptoms before surgery
Median days of symptomsa 13 4 [3–6] 7 5 [5–6] 0.08
Symptom duration <4 days 9/13 69% 1/7 14%
Symptom duration >4 days 4/13 31% 6/7 86% 0.02
Marital status
Unmarried 7/13 54% 3/7 43%
Married 6/13 46% 3/7 43%
Divorced 0/13 0% 1/7 14% 0.37
Unemployed 7/13 54% 4/7 55% 1.0
History of gastritis 10/13 77% 4/7 57% 0.61
Smoking 8/13 38% 4/7 57% 0.64
Alcohol 11/13 85% 5/7 71% 0.59
<2 meal per day 2/13 15% 0/7 0% 0.51
Rh+ 11/13 92% 4/7 80% 0.52
ABO
A 0 0% 0 0%
B 2/13 17% 2/7 29%
AB 1/13 8% 0/7 0%
O 9/13 75% 5/7 71% 0.64
a Median [interquartile range].
Table 3 Risk-factors for in-hospital mortality, univariate and
multivariate regression.
b [95% CI] p-Value
Univariate
Age >30 years 2.60 [0.18–5.03] 0.035
Symptom duration >4 days 2.60 [0.18–5.03] 0.035
Multivariate
Age >30 years 2.95 [0.02–5.88] 0.049
Symptom duration >4 days 2.95 [0.02–5.88] 0.049
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status of the patient and his or her social network. The time
between admission and surgery was not prospectively col-
lected, and since this information was not available upon ret-
rospective review of the medical ﬁles we were not able to
evaluate the trade-off between emergent surgery and preoper-
ative resuscitation. Similarly, the rates of post-operative com-
plications such as bleeding, protracted pain, infection, and
wound dehiscence were not prospectively recorded and were
not comprehensively available upon retrospective review.
These missing data points considerably limit the granularity
and generalizability of our conclusions. Lack of patient educa-
tion and burdensome ﬁnancial costs associated with obtaining
health care represent two substantial barriers to adequate post-
operative follow-up that warrant further study. In Liberia, as
in many low-income settings, poor patient follow-up is
multifactorial.
Despite the proven cost-effectiveness of surgical services in
low- and middle-income countries,13 currently an approximate
2 billion people world-wide do not have access to surgery.14
The World Bank recently emphasized the global maldistribu-
tion of surgical providers, lack of surgical infrastructure and
detrimental out-of-pocket payment for surgery, and the World
Health Assembly may in 2015 vote for a resolution toward uni-
versal access to safe affordable surgery and anesthesia with
ﬁnancial protection.15 Liberia is a country where the scarcity
of surgical and anesthesia infrastructure and care personnel
has been particularly well documented.14–17
As the only tertiary academic medical facility in Liberia,
our institution hopes to establish a culture of data collection
and analysis, as well as of outcomes monitoring through stud-
ies such as this and other prospective studies in the future.
Ultimately, these data will help inform clinical practice to pro-
vide improvements in surgical quality and healthcare outcomes
for all Liberians. Our results help to establish a baseline under-
standing of the impact of surgery for peptic ulcer disease
within our community. Bringing surgical disease out of the
OR and directly into the public health system strengthening
arena will highlight the importance of education and primary
prevention from a health system standpoint.
Conclusion
Mortality from peptic ulcer disease remains high in low- and
middle-income countries, and early surgical management can
be life saving. Timely referrals and treatment of modiﬁable risk
factors may prevent late-stage complications, though access to
treatments and longitudinal care remains a signiﬁcant chal-
lenge. Future studies should take into consideration the use
of NSAIDs and the presence of H. pylori, and the role of pri-
mary and secondary prevention.
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